{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By ROBERT CYRAN", "person": [{"firstname": "Robert", "rank": 1, "lastname": "CYRAN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "381", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "Company Reports", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Amgen Inc", "is_major": "N", "name": "organizations"}, {"rank": "5", "value": "AmerisourceBergen Corp", "is_major": "N", "name": "organizations"}, {"rank": "6", "value": "Endo International PLC", "is_major": "N", "name": "organizations"}, {"rank": "7", "value": "Express Scripts Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "Intensifying pressure stands to upend business models heavily dependent on raising prices.", "pub_date": "2016-11-08T18:38:54Z", "document_type": "article", "source": "The New York Times", "snippet": "Intensifying pressure stands to upend business models heavily dependent on raising prices....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/11/09/business/dealbook/valeants-struggles-are-a-bad-omen-for-the-entire-industry.html", "slideshow_credits": null, "blog": [], "_id": "58221bc67c459f6a5fccce68", "headline": {"main": "Valeant\u2019s Struggles Are a Bad Omen for the Entire Industry", "content_kicker": "Breakingviews"}}